brello health glp-1 WEEKLY GLP-1 Update! Week 7
Description
This highlights the need for careful evaluation of the efficacy and safety profile of AOMs in the older population
Morel P, Tallineau C, Pontcharraud R, Piriou A, Huguet F
The primary mechanism involves delayed gastric emptying, which means the stomach releases food into the small intestine much more slowly than it would naturally
Wegovy is the injectable brand of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
Kappe et al., 2012)
Regul Pept 151(13):123129
